Cambrex Opens New Stability Storage Facility in Durham, North Carolina
- Cambrex has expanded its stability storage capabilities by opening a new advanced facility in Durham, North Carolina, aimed at servicing the pharmaceutical and life sciences industries with state-of-the-art environmentally-controlled storage conditions.
- The facility is strategically located near Research Triangle Park and is part of Cambrex's phased expansion plans, which will increase storage capacity to support the growing demand for drug development services in North America.
- The expansion in Durham complements Cambrex's facilities in Ireland and Belgium, enhancing delivery services with faster turnaround times and expanded temperature-controlled transport options across the US and Europe, reflecting Cambrex CEO Tom Loewald's commitment to strategic growth and customer service enhancement.
Join Our Newsletter
Get the latest news, updates, and exclusive content delivered straight to your inbox.
In a significant move to enhance its services for the pharmaceutical, medical device, and life sciences industries, Cambrex, a leading global contract development and manufacturing organization (CDMO), has announced the opening of a new state-of-the-art stability storage facility in Durham, North Carolina. This expansion marks a major step in Cambrex’s commitment to providing advanced storage solutions that meet the evolving needs of its clients.
A Leader in CDMO Services
Cambrex is renowned for its extensive expertise in drug substance development and manufacturing across the entire drug lifecycle. With over 40 years of experience and a team of 2,000 experts servicing global clients from North America and Europe, Cambrex offers specialized drug substance technologies and capabilities, including continuous flow, controlled substances, solid-state science, material characterization, and highly potent APIs.
The New Facility: A Hub for Advanced Stability Storage
The new facility, part of Q1 Scientific, Cambrex’s dedicated stability storage business, is strategically located in Research Triangle Park (RTP), Durham, North Carolina. This co-location with Cambrex’s existing analytical facility ensures seamless integration and enhances operational efficiency.
Advanced Storage Capabilities
The facility boasts advanced environmentally-controlled storage capabilities, featuring seven ICH stability chambers. These chambers offer a range of conditions crucial for pharmaceutical testing:
- 2-8°C
- 25°C/40%RH
- 25°C/60%RH
- 30°C/65%RH
- 40°C/75%RH
- -20°C
- Ultra Low (-70°C/-80°C)
These conditions are essential for ensuring the stability of pharmaceutical products during various stages of development and manufacturing.
Phase Two: Expanding Capacity
The new facility is not just a one-time investment; it is part of a phased expansion plan. In the next two years, the facility’s capacity will be increased to 20 chambers, potentially providing 20,000 cubic feet of storage space. This significant increase in capacity will enable Cambrex to meet the growing demand for outsourced drug development and manufacturing services across North America.
Enhancing Delivery Services
Located in RTP, the facility’s proximity allows for same-day and next-day delivery services across the United States. This rapid delivery capability is a significant advantage for clients, ensuring that samples are transported efficiently and effectively, minimizing delays in testing and development.
Global Footprint and Customer Benefits
Cambrex’s expansion into Durham complements its existing facilities in Waterford, Ireland, and Liège, Belgium. This global footprint allows Q1 Scientific to offer faster turnaround times for sample return and greater temperature-controlled transport options across the US and Europe. Stephen Delaney, Managing Director of Q1 Scientific, highlighted the benefits, stating: “Operating three sites globally will be a significant benefit to our customers, who can now expect faster turnaround times for the return of samples and greater temperature-controlled transport options across the US and Europe”.
CEO Tom Loewald’s Vision
Tom Loewald, CEO at Cambrex, expressed his excitement about the expansion, emphasizing the strategic importance of this investment. He stated: “We are thrilled to expand Q1 Scientific’s reach into Durham, North Carolina, enhancing our ability to serve pharmaceutical companies across North America. This investment not only broadens our footprint but also leverages Q1 Scientific’s extensive expertise in the stability storage business”.
Conclusion
Cambrex’s new stability storage facility in Durham, North Carolina, is a testament to the company’s commitment to innovation and customer satisfaction. By expanding its capacity and enhancing its delivery services, Cambrex is poised to meet the increasing demands of the pharmaceutical and life sciences industries. This strategic move solidifies Cambrex’s position as a leading CDMO, offering comprehensive services that support the development and manufacturing of critical medications and medical devices.
References
- https://www.cambrex.com/locations/durham-nc-usa/
- https://www.cambrex.com/news/cambrex-to-expand-stability-storage-business-with-new-facility-in-durham-north-carolina/
- https://pharmasource.global/content/news/cdmo-news/cambrex-enhances-stability-storage-with-durham-expansion/
- https://www.prnewswire.com/news-releases/cambrex-to-expand-stability-storage-business-with-new-facility-in-durham-north-carolina-302190242.html
